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Abstract Spinocerebellar ataxias (SCAs) have irregular
distributions worldwide. SCA1 is the most frequent in
Poland, and no cases of SCA3 of Polish origin has yet been
identified. In view of such patterns of SCAs occurrence, the
relative frequency, geographical distribution and a possible
founder effect of SCA1 were investigated. DNA samples of
134 probands with SCA1 and 228 controls were analysed.
The genotyping of four markers, D6S89, D6S109, D6S274,
D6S288, around the ATXN1 gene (SCA1) and sequencing
of the selected variant of D6S89 were performed. The
relative frequency of SCA1 was 68 %. The studied SCA1
pedigrees were irregularly distributed, with the highest
concentration in Central Poland. Haplotyping revealed the
association of ATXN1 gene mutation with a 197-bp variant
of D6S89 marker (63 % of probands) and with a 184-bp
variant of DS6274 (50.7 % of probands). Out of 61 SCA1
probands from Mazowieckie, 41 carried the same 197-bp
variant. SCA1 relative frequency in Poland shows the
highest value compared with the data from other countries
worldwide. Due to the association with the mutation
obtained for the investigated markers and the SCA1 pedi-
grees concentration in Central Poland, we hypothesise that
it represents a potential founder effect.
Keywords Rare neurodegenerative disorders 
Spinocerebellar ataxia (SCA)  Founder effect
Introduction
Spinocerebellar ataxias (SCAs) belong to a group of
hereditary neurodegenerative disorders that represent a
wide spectrum of clinical and neuropathological symp-
toms. Due to their approximated worldwide prevalence of
3:100,000, SCAs are assumed to be rare disorders. SCA3 is
the most common subtype worldwide, followed by SCA1,
2, and 6. Depending on the geographical region, these 4
types account for approximately 75 % of all SCA familial
cases. [1, 2].
The prevalence of particular subtypes differs in various
ethnic groups and continents. The most spectacular
examples are Holguin Province in Cuba, where SCA2
occurs at an estimated frequency of 41 cases per 100,000
individuals [3, 4] and Flores Island, which belongs to the
Azores Archipelago, where up to 714 SCA3 cases per
100,000 were observed [5]. Such regional differences of
the occurrence of some SCA types are the result of a
founder effect, a phenomenon documented in a few pop-
ulations, for example in Brazilian, Portuguese and Japanese
patients for SCA3 [6, 7], in Scandinavian patients for
SCA7 [8] and Mexican patients for SCA10 [9].
Contrary to the highest SCA3 frequency in the majority
of Western European countries, in Poland and the Czech
Republic, no cases of this SCA type have yet been iden-
tified among patients originating from these two countries
[10, 11]. In the Czech Republic, the absence of SCA3
might result from lower frequencies (less than 0.1 %) of
large normal alleles carrying [27 CAG repeats in the
Czech control group (the range 13–34 CAG repeats)
compared with Caucasians and other genetic factors, such
as the presence or absence of certain haplotypes. Similarly,
the genotyping of the ATXN3 gene in Polish controls also
revealed a lower normal range (14–32 CAG repeats)
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compared with other Caucasians (14–40 CAG repeats) [12,
13]. In contrast to the SCA3 locus, the range of 25–38
CAG and the mean allele size of 31.15 CAG triplets for the
SCA1 (ATXN1) gene were slightly higher in the Polish
group than in other genotyped Caucasian individuals
(25–37 CAG, mean allele size 30.10).
In addition to 138 SCA1 pedigrees in Poland, 23 SCA2,
1 SCA3 (one pedigree originating from Germany), 38
SCA8 and 3 SCA17 pedigrees were identified.
Considering this pattern of SCA types occurrence in
Poland, we attempted to determine whether these effects
reflected the founder effect for SCA1.
Materials and methods
The statistical analyses of the relative SCA1 frequency in
Poland and investigation of its geographical distribution
were performed for 138 unrelated probands representing
138 different families (previously verified SCA1 mutation
carriers). The haplotyping analyses were carried out for
134 DNA samples of SCA1 probands. The control group
comprised 228 healthy unrelated individuals (ages ranging
from 19 to 96 years, mean age of 52 years). DNA samples
were extracted from peripheral blood leukocytes using a
standard phenol/chloroform method or automated isolation
on a MagNA Pure Compact (Roche Instrument Center AG,
Rotkreuz, Japan). The molecular methods for microsatel-
lites repeats genotyping involved polymerase chain reac-
tion (PCR) and electrophoresis in 5 % polyacrylamide gels
of fluorescently labelled PCR products with the internal
size marker TAMRA350 on an ABI Prism 377 plate
sequencer (Applied Biosystems, Foster City, CA, USA)
under denaturing conditions. The primer sequences used
for genotyping and sequencing have been described pre-
viously: D6S89 [14], D6S109 [15], D6S274 [16], D6S288
[17].
Sequencing of the D6S89 CA polymorphism was per-
formed using the BigDye Terminator v.3.1, followed by
electrophoretic separation on the genetic analyser ABI3110
(Applied Biosystems/Hitachi, Tokyo, Japan). To determine
the number of CA repeats in a 197-bp variant, sequencing
was performed in the 5 DNA samples of SCA1 individuals.
Differences in the allele distribution between control
and carrier chromosomes were evaluated using X2 analysis
and Fisher’s exact test. The presence of LD was tested
using HWE LR Chi-square for genetic markers (Statistical
Genetic Utility Programs by J. Ott v.2007). A difference
was considered statistically significant if p\ 0.001.
The geographic distribution of the 138 SCA1 pedigrees
was determined according to the data from files archived in
the Genetics Department, Institute of Psychiatry and
Neurology, Warsaw, Poland. The first criterion used to
designate the region of origin of the SCA1 family was the
place of birth of the oldest affected family member, and the
second criterion, when the first was unavailable or
unknown, was the address of the permanent residence. The
region of descent was determined for 127 pedigrees: 120
pedigrees originated from Poland, 7 pedigrees originated
from eastern neighbouring countries, and no data were
available for the remaining 11 pedigrees. The administra-
tive division of the country into 16 voivodships corre-
sponded to the regions of origin.
Informed consent was obtained from all participants.
This study was approved by the Bioethical Commission of
The Institute of Psychiatry and Neurology, Warsaw.
Results
Relative SCA1 frequency
Relative frequency of SCA1 (68 %) was assessed con-
sidering the number of SCA1 pedigrees (138 probands)
versus the overall number of molecularly confirmed ADCA
pedigrees: 138 SCA1, 23 SCA2 1 SCA3, 38 SCA8 and 3
SCA17 (203 probands/families). A similar frequency
(67 %) was obtained considering all SCA1 mutation car-
riers (258) versus all molecularly verified subjects with the
types of ADCA described above (383).
Geographical distribution of SCA1 pedigrees
in Poland
According to the geographical distribution study, 61
pedigrees affected with SCA1, accounting for 48 % of the
analysed pedigrees, originated from Mazowieckie voivod-
ship, where 13.7 % of the total Polish population resided,
in concordance to the Statistical Yearbook of the Regions
[18]. The other two regions of Poland, centrally located,
where SCA1 cases were relatively numerous were
Wielkopolskie (14 pedigrees) and Lodzkie (10 pedigrees).
Among 138 pedigrees, 88 pedigrees (63.8 %) originated
from the above named 3 voivodships in which SCA1 was
more frequently observed. Seven pedigrees were of foreign
origin: four pedigrees from Ukraine, two pedigrees from
Russia and one pedigree from Belarus. Figure 1 provides
the distribution of the 120 SCA1 pedigrees of Polish origin,
and the percentage of all SCA mutation carriers identified
(symptomatic and asymptomatic) in the voivodships is
indicated in parentheses. Notably, although the largest
population is located in Mazowieckie (5293.2 thousands),
the highest percentage of SCA1 mutation carriers
(0.002–129 SCA1 mutations) was observed, which sug-
gests that SCA1 prevalence may be about 1: 41.031
(*2.5:100,00). In the other voivodships, the prevalence of
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the mutated ATXN1 gene carriers is at least 10 or 100 times
lower compared with Mazowieckie. The assessed overall
mean prevalence of SCA1 in Poland is approximately
1:100,000 individuals (assuming that most of the affected
pedigrees have been identified).
Haplotyping study
The dinucleotide polymorphisms of genetic markers
spanning the region around locus ATXN1 (SCA1), D6S89,
D6S109, D6S274, and D6S288, were analysed in the group
of individuals carrying the CAG repeat expansion and
controls. The obtained results established the allele fre-
quencies for each marker to determine whether any dise-
quilibrium existed between the studied groups. The
analysed variants frequencies (calculated for alleles) are
shown in Table 1.
Further statistical analyses (Table 2) were performed for
the allelic variants of the two markers, which were selected
according to a value of p = 0.001 and confirmed the sig-
nificant differences between both studied groups (calcu-
lated for the subjects studied). Association was calculated
using Fisher’s exact test, and a p value\0.001 was con-
sidered significant. The first allele, corresponding to the
197-bp variant of D6S89, was overrepresented (p\ 0.001)
in the carriers of the expanded chromosomes compared
with unexpanded chromosomes. Moreover, of the 61 pro-
bands from Mazowieckie voivodship, the 197-bp allele was
detected in 41 probands. For the second D6S274 marker an
allelic variant, corresponding to the 184 bp, was also more
frequent in SCA1 individuals than in controls (Table 2).
Overall, the haplotype D6S89/D6S274 (197/184 bp) was
observed in 46 probands among 134 individuals studied
(34 %) versus the control group, where of the 228 indi-
viduals analysed, 8 individuals (3.5 %) carried the same
variants. Additionally, among the 46 subjects with SCA1
carrying the 184-bp variant of D6S274, 10 subjects were
homozygous for this variant.
Sequencing of the 197-bp allele sized through geno-
typing (fragment analysis) revealed the presence of 22 CA
repeats.
Discussion
According to the available epidemiological data, SCA1 is
the most prevalent genetic type of SCA in Poland, as the
relative frequency of SCA1 (68 %) and the number of
Fig. 1 Geographic distribution
of 120 SCA1 pedigrees of
documented Polish origin. The
number of SCA1 pedigrees
(probands) is shown in the
frame with the name of the
voivodship, and the prevalence
of SCA1 mutation carriers
(symptomatic and
asymptomatic) calculated per
voivodship population is shown
in parentheses
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identified pedigrees (138) is the highest compared with the
data from other countries. Interestingly, the SCAs profile
was most similar to that identified in Italy, with SCA1 as
the most common type [19, 20]. Based on the Italian data,
the SCA1 relative frequency in this country ranges from
13.9 % [21], 31.8 % [22], 42.9 % [20] to 58.9 % [19] and
also shows the irregular distribution, with significantly
higher density of SCA1 pedigrees in the northern part of
the country. The other country where SCA1 seems to be
more prevalent is Russia, with a relative frequency of 33 %
[23], although it might be underestimated, due to the small
number of families studied.
Similarly to Italian studies, the SCA1 distribution in
Poland is irregular, with the highest concentration of
pedigrees occurring in Mazowieckie voivodship [11].
We assumed that these results partially reflect the
selection bias which was caused by availability of genetic
testing for SCAs restricted at the time of the study to the
Genetic Department (IPN Warsaw). Additionally, such
irregular distribution of SCA1 may have also resulted from
limited access to specialised medical centres throughout
the country. However, the analysis of the geographical
distribution of SCA1 families, especially those with at least
three generations, revealed their actual concentration in the
Central Poland (Mazowieckie). Moreover, their members
were not in favour of changing residence. When changes in
residency were observed, moving out the place of family
origin was primarily confined to the same region. Although
Mazowieckie has the largest population (5293.2 thousands
of inhabitants), the highest prevalence (0.002 %) of SCA1
mutation carriers was found.
Additionally, the haplotyping study revealed that
among the 61 SCA1 probands from this region, 41 pro-
bands carried the same 197-bp variant of the D6S89
marker, which is strongly associated with the ATXN1
locus. This finding suggests that the mutation might have
derived from this region, thus representing an example of
the founder effect.
The haplotyping within the group of Polish SCA1-af-
fected families revealed two statistically significant asso-
ciations: the 197-bp D6S89 marker variant, coinherited
with the mutation in 84 pedigrees, and the 184-bp D6S274
marker variant, coinherited with the mutation in 64 pedi-
grees. However, both variants were identified only in 46
probands. In view of the relatively high number of indi-
viduals homozygous for the 184-bp DS6274 variant, we
assumed that this result does not show a considerably
strong association with the SCA1 causative mutation.
Additionally, the region size between these polymorphisms
was approximately 1.2 Mb [16]; probably therefore, a
relatively low number of probands carrying the haplotype
was identified in the studied group.
Table 1 Allele frequencies of the analysed markers in the studied group of 134 SCA mutation carriers and 228 controls and statistical
significance of the differences between the groups studied





D6S89 197 86/268 (0.321) 37/456 (0.081) 68.80 0.00001
193 54/268 (0.201) 108/456 (0.237) 1.21 0.2705
D6S274 184 80/268 (0.298) 36/456 (0.079) 60.48 0.00001
174 44/268 (0.164) 130/456 (0.285) 13.52 0.0002
D6S109 185 99/268 (0.369) 192/456 (0.421) 1.87 0.1711
D6S288 234 129/268 (0.481) 215/456 (0.471) 0.07 0.7978
232 79/268 (0.295) 105/456 (0.230) 3.71 0.05663
a The studied group comprised 134 SCA1 mutation carriers (probands) (268 alleles)
b The control group comprised 228 unaffected individuals (456 alleles)
Table 2 Analysis of the association between the polymorphic marker variants and SCA1 in the group of mutation carriers analysed using
Fisher’s exact test
Marker Allele (bp) Controlsb Mutation carriersa LR likelihood ratio (2p) Fisher’s test (p) D’ linkage disequilibrium
parameter
D6S89 197 37/228 84/134 0.0000 0.0000 -0.514
D6S274 184 36/228 68/134 0.0000 0.0000 -0.450
174 130/228 37/134 0.0000 0.0000 ?0.401
a The studied group comprised 134 SCA1 mutation carriers (probands)
b The control group comprised 228 unaffected individuals
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Comparing to our study, different methodological
approaches in genotyping were found in majority of the
reviewed articles. In previous studies, the size of D6S89
allelic variants was based on PCR amplification with
radiolabelled primers and visualisation of amplicons on
films after exposure to 4 or 6 % polyacrylamide denaturing
gels [24–26]. Moreover, several studies have only reported
the number of associated markers, without revealing the
size in base pairs and data concerning the number of CA
dinucleotides within these polymorphisms [27, 28].
Therefore, in the present study sequencing analysis of the
197-bp variant of the D6S89 marker was performed in five
members of the two largest families, in whom this variant
was coinherited with the SCA1 mutation, as shown in
Fig. 2. We have determined that the 197-bp allele sized
through genotyping contained 22 CA repeats.
Considering these different methodological approaches,
we had limited information to compare the investigated
polymorphisms according to the size in base pairs and/or to
the sequence.
The search for available reports revealed that the same
D6S89 marker variant of 197 bp was associated with the
SCA1 mutation in 2 large Italian families originating from
Calabria [24].
In all affected subjects (83 individuals) in both families,
similarly to our study, the same D6S89 (197 bp) variant
was identified. The authors suggested that this variant
originated from a common ancestor according to family
I-1
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Fig. 2 An example of the SCA1 pedigree with the 197-bp D6S89 variant segregating with the mutation
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studies revealing the potential relationship dating back to
the early 1700s. This assumption is supported by the low
recombination frequency (less than 1 %) between both
loci: SCA1 and D6S89 [29]; therefore, this dinucleotide
polymorphism has been considered a highly informative
marker prior to the SCA1 gene identification and was
recommended for use in linkage analyses in the affected
families [30, 31]. For example, in the study of Khati et al.
[25], involving ten families with ADCA type 1, the linkage
with the D6S89 was observed in four families. However,
the analysed marker variants (209, 205, 201, and 193 bp)
coinherited with the mutation were different in every
pedigree. The authors postulated that this result might
reflect the independent occurrence of the SCA1 mutation in
these four kindreds originating from different regions of
France.
Jodice and co-workers performed haplotyping to delin-
eate the SCA1 locus in eight Italian kindreds [26]. The
established haplotype segregating with the disease locus
included four microsatellite markers, D6S288 (233 bp),
D6S89 (197 bp), D6S260 (157 bp), and D6S289 (223 bp),
considered as specific to the southern region of the country.
Another genotyping study of two SCA1 flanking poly-
morphisms, D6S89 and D6S274 [32], in seven pedigrees of
the Siberian Yakut population revealed an association with
the disease locus. Moreover, Goldfarb et al. previously
described the founder effect in Yakuts [33], but no
molecular analyses were performed at that time. Despite
the relatively low number of subjects (7 families with 17
mutation carriers), informative data were obtained for both
microsatellites, showing an association of a 174-bp allele
(D6S274) in five pedigrees, a 199-bp allele (D6S89) in five
families and a 205-bp allele in one family. The authors
postulated that the two independent historical recombina-
tion events between the SCA1 gene and D6S89 marker
resulted in a switch to the allele of 205 bp which may be
consistent with the different regions of origin documented
for two families from Southern and Northern Siberian
villages.
Conclusion
In Poland, the relative frequency of SCA1 among other
molecularly identified types of SCA was 68 %, showing
the highest value compared with the data from other
countries in Europe and worldwide.
The distribution of SCA1 in Poland is irregular. The
highest concentration of SCA1 pedigrees was observed in
the centrally situated Mazowieckie voivodship. Haplotyp-
ing analyses revealed the association of ATXN1 gene
mutation with a 197 bp (bearing 22 CA repeats) D6S89
marker variant (in 84 out of 134 probands—63 %). Among
the 61 SCA1 probands from Mazowieckie, 41 probands
carried the same 197-bp variant. We hypothesise that the
mutation might have occurred in the Central Poland region
and that it represents a potential founder effect.
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